Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | Cavailles |
|---|---|
| Group name | EquipeVC |
| Item Type | Attachment |
| Title | Texte intégral |
| URL | https://translational-medicine.biomedcentral.com/track/pdf/10.1186/s12967-020-02271-6 |
| Accessed | 2021/09/01 - 19:17:31 |
| Date Added | 2021/09/01 - 17:17:31 |
| Date Modified | 2021/09/01 - 17:17:31 |
| Parent item | Cytoplasmic PPAR? is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de